STATE UNIVERSITY OF NEW YORK AT BUFFALO
Lipid mediated oral tolerance
Lipid mediated oral tolerance is a funding opportunity from STATE UNIVERSITY OF NEW YORK AT BUFFALO, up to 931012, closing May 31, 2027.
May 31, 2027
(304d left)Overview
Project Summary: Autoimmune conditions, allergies and immunogenicity against therapeutic proteins are caused by unwanted immune responses against proteins. Our long-term goal is to rationally develop an immunotherapy platform using protein delivery strategies to treat these clinical conditions. We observed that an…